These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 9814049)

  • 61. Prevention and treatment of nosocomial infections, with special reference to antibiotic policy.
    Výmola F; Janovská D
    J Hyg Epidemiol Microbiol Immunol; 1986; 30(3):283-6. PubMed ID: 3772091
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Homotypic and heterotypic interfering activity associated with measles and subacute sclerosing panencephalitis viruses.
    Gardner P; Bennett JV; Burke JP; McGowan JE; Wenzel RP
    J Infect Dis; 1980 Mar; 141(3):415-7. PubMed ID: 6767796
    [No Abstract]   [Full Text] [Related]  

  • 63. Multicenter pilot survey of resistant bacteria in the Mediterranean area.
    Amazian K; Fendri C; Missoum MF; Bouzouaia N; Rahal K; Savey A; Saadatian-Elahi M; Fabry J
    Eur J Clin Microbiol Infect Dis; 2006 May; 25(5):340-3. PubMed ID: 16601956
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Questionnaire on prevalence of methicillin-resistant Staphylococcus aureus and penicillin-resistant Streptococcus pneumoniae and sensitivity of Pseudomonas aeruginosa in 2004 in Kinki District].
    Kasahara K; Mori K; Uno K; Maeda K; Yoshimoto E; Konishi M; Koizumi A; Sano R; Mikasa K
    Kansenshogaku Zasshi; 2007 May; 81(3):309-11. PubMed ID: 17564122
    [No Abstract]   [Full Text] [Related]  

  • 65. Association between hand hygiene compliance and methicillin-resistant Staphylococcus aureus prevalence in a French rehabilitation hospital.
    Girou E; Legrand P; Soing-Altrach S; Lemire A; Poulain C; Allaire A; Tkoub-Scheirlinck L; Chai SH; Dupeyron C; Loche CM
    Infect Control Hosp Epidemiol; 2006 Oct; 27(10):1128-30. PubMed ID: 17006822
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [The good use of antibiotics in intensive care: results of a program for rationalization of prescriptions].
    Mohammedi I; Duperret S; Védrinne JM; Allaouchiche B; Bui-Xuan B; Boulétreau P
    Ann Fr Anesth Reanim; 1998; 17(1):27-31. PubMed ID: 9750679
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Antibacterial resistance in the intensive care unit: mechanisms and management.
    Elliott TS; Lambert PA
    Br Med Bull; 1999; 55(1):259-76. PubMed ID: 10695090
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Epidemiology and mechanisms of resistance: clinical and environmental impact].
    Drago L
    Infez Med; 2007 Sep; 15 Suppl 2():6-12. PubMed ID: 17940407
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Import of multiresistant strains of Staphylococcus aureus. Preventive measures against epidemic spread in a hospital environment].
    Nielsen PB; Espersen F; Hansen BS; Jensen K; Lund K; Sørensen B
    Ugeskr Laeger; 1982 Jan; 144(3):133-6. PubMed ID: 7080235
    [No Abstract]   [Full Text] [Related]  

  • 70. [Multidrug-resistant bacteria in the hospital: the focus of nursing care].
    Chung HC; Lee RP
    Hu Li Za Zhi; 2011 Aug; 58(4):11-5. PubMed ID: 21809282
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The sleeping giant. Antimicrobial resistance.
    Casellas JM; Blanco MG; Pinto ME
    Infect Dis Clin North Am; 1994 Mar; 8(1):29-45. PubMed ID: 8021447
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Lipid compositions of two penicillin-resistant bacteria, Staphylococcus aureus (met R 18) & Bacillus licheniformis (749/C).
    Goswami R; Chowdhury MK; Chakrabarti P
    Indian J Biochem Biophys; 1982 Jun; 19(3):217-20. PubMed ID: 7173961
    [No Abstract]   [Full Text] [Related]  

  • 73. Hospital staphylococci and the new penicillins.
    Barber M
    Minerva Med; 1965 Sep; 56(73 Suppl):3058-9. PubMed ID: 5838809
    [No Abstract]   [Full Text] [Related]  

  • 74. Mechanisms of antimicrobial resistance: their clinical relevance in the new millennium.
    Sefton AM
    Drugs; 2002; 62(4):557-66. PubMed ID: 11893225
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Progress in chemotherapeutic agents--penicillins].
    Saito A
    Nihon Rinsho; 1986 Apr; 44(4):814-7. PubMed ID: 3093731
    [No Abstract]   [Full Text] [Related]  

  • 76. Recognising and controlling risk factors for antimicrobial resistance.
    Lloyd D
    Schweiz Arch Tierheilkd; 2010 Mar; 152(3):131-4. PubMed ID: 20235014
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Changes in the resistance behavior of Staphylococcus aureus to penicillin and tetracycline under the direct effect of antimicrobial chemotherapy].
    Schulz S; Haerting J
    Z Gesamte Hyg; 1984 May; 30(5):275-8. PubMed ID: 6566501
    [No Abstract]   [Full Text] [Related]  

  • 78. Increasing prevalence of antimicrobial resistance in intensive care units.
    Fridkin SK
    Crit Care Med; 2001 Apr; 29(4 Suppl):N64-8. PubMed ID: 11292878
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [How dangerous are multiresistant bacteria in the hospital].
    Barck H; Pogge A
    Pflege Z; 1998 May; 51(5):350-3. PubMed ID: 9661493
    [No Abstract]   [Full Text] [Related]  

  • 80. Water sources and environmental transmission of multiply resistant enteric bacteria in rural Bangladesh.
    Shears P; Hussein MA; Chowdhury AH; Mamun KZ
    Ann Trop Med Parasitol; 1995 Jun; 89(3):297-303. PubMed ID: 7668921
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.